Medical Oncologist at Beverly Hills Cancer Center
Hematology
Dr. David Berz, MD
|
|
Give Review
David Berz, MD practices Hematology. David Berz is a published doctor as well. He has 22 publications published. The latest was: Novel compound 1,3-bis (3,5-dichlorophenyl) urea inhibits lung cancer progression. Dr. David Berz is registered with Medicare.
Publications
- Novel compound 1,3-bis (3,5-dichlorophenyl) urea inhibits lung Cancer progression.
- Lenalidomide for Second-line Treatment of Advanced Hepatocellular Cancer: A Brown University Oncology Group Phase II Study.
- Survival of patients with squamous cell malignancies of the upper urinary Tract.
- Cremophor-induced lupus erythematosus-like reaction With taxol administration: a case report and review of the literature.
- Marrow cell genetic phenotype change induced by human lung Cancer cells.
- Targeting the growth factors and angiogenesis pathways: small molecules in solid Tumors.
- Pesticides and non-Hodgkin Lymphoma: an overview for the clinician.
- Do race and ethnicity predict survival in metastatic non-small cell lung Cancer?
- Alphabet soup: RAEB, HMA, DOE, and AFOP.
- The neoadjuvant therapy of coloRectal hepatic metastases and the role of biologic sensitizing and resistance factors.
- Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct deLivery of mRNA and induction of transcription.
- Triple MEL100 therapy in multiple myeloma.
- Pneumonectomy after neoadjuvant chemotherapy and radiation for advanced-stage lung Cancer.
- Heterogeneity of non-cycling and cycling synchronized murine hematopoietic stem/progenitor cells.
- Nonengraftment haploidentical cellular immunotherapy for refractory malignancies: tumor responses Without chimerism.
- Left sided inferior vena cava duplication and venous thromboembolism: case report and review of literature.
- ''Weighing in'' on screening mammography.
- Extreme hyperlymphocytosis.
- Targeting small molecules in Cancer.
- HER family inhibitors in pancreatic Cancer: current status and future directions.
- Cryopreservation of hematopoietic stem cells.
Schools
Humboldt University
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Brown University -
Humboldt University of Berlin- Charite Faculty of Medicine
Hospital
-
Lakewood Regional Medical Center
Drug Facts
| NPI NUMBER | 1437375128 | |
| NPPES Provider LastName | BERZ | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 902415018 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 952.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 90.0 | |
| Percent Opioid Claims | 9.45 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1437375128 |
| Last Name Of The Provider | BERZ |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
Dr. Jack H. Freimann Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Lisa S. Wang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dustin E. Stevenson, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edwin Y. Lin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frederick L. Williams, MD |
|
|
Dr. Merrill K. Shum, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Glenn A. Tisman, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|